title: Regulation by membrane sialic acid of beta1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway.
abstract: Sheep erythrocytes in their native state did not activate the alternative complement pathway, as measured by lysis in dilutions of normal human serum containing [ethylenebis(oxyethylenenitrilo)] tetraacetic acid but acquired this capacity after membrane sialic acid residues had been removed (by sialidase) or modified (by NaIO(4)). Activation of the alternative pathway by sheep erythrocytes required removal or modification of at least 40% of the membrane sialic acid to reach threshold, and it increased proportionately when larger amounts of sialic acid had been affected. Studies with isolated proteins of the alternative pathway demonstrated that the altered erythrocyte membranes resembled natural activators in protecting bound C3b from inactivation by C3b inactivator and beta1H and protecting bound amplification C3 convertase (C3b,Bb) from decay-dissociation by beta1H. A 1% decrease in intact sialic acid was associated with a 1% decrease in beta1H activity in decay-dissociation of membrane bound C3b,Bb. Because removal of the C8 and C9 carbon atoms from the polyhydroxylated side chain of sialic acid by oxidation with NaIO(4) was functionally equivalent to removal of the entire sialic acid moiety, secondary effects of the latter reaction, such as diminution of the negative charge of the membrane or exposure of penultimate galactose residues, were not considered to be responsible for the altered activity of beta1H. These studies suggest that facilitation, by membrane sialic acid residues, of the interaction between bound C3b and beta1H is essential to prevent the particle from effectively activating the alternative pathway.
mesh_terms: D000818:Animals; D003166:Complement Activating Enzymes / Q000378:metabolism*; D050577:Complement C3-C5 Convertases / Q000378:metabolism*; D003179:Complement C3b / Q000378:metabolism*; D003180:Complement C3b Inactivator Proteins / Q000378:metabolism / Q000494:pharmacology; D011415:Complement Factor B / Q000378:metabolism; D004912:Erythrocytes / Q000276:immunology*; D006023:Glycoproteins / Q000276:immunology; D008565:Membrane Proteins / Q000276:immunology; D012756:Sheep / Q000276:immunology; D012794:Sialic Acids / Q000276:immunology*
chemical_list: D003180:Complement C3b Inactivator Proteins; D006023:Glycoproteins; D008565:Membrane Proteins; D012794:Sialic Acids; D003179:Complement C3b; D003166:Complement Activating Enzymes; D050577:Complement C3-C5 Convertases; D011415:Complement Factor B
references.citation: Proc Soc Exp Biol Med. 1964 Dec;117:643-50
references.pmid: 14244915
references.citation: J Exp Med. 1964 Nov 1;120:841-56
references.pmid: 14247724
references.citation: Blood. 1961 Jan;17:83-96
references.pmid: 13787034
references.citation: J Biol Chem. 1959 Aug;234(8):1971-5
references.pmid: 13672998
references.citation: Science. 1954 Aug 20;120(3112):279-85
references.pmid: 13186838
references.citation: J Immunol. 1977 Aug;119(2):614-7
references.pmid: 69664
references.citation: J Exp Med. 1976 Nov 2;144(5):1147-63
references.pmid: 62817
references.citation: Science. 1977 Mar 4;195(4281):878-80
references.pmid: 402691
references.citation: Fed Proc. 1977 Aug;36(9):2191-6
references.pmid: 328305
references.citation: J Exp Med. 1977 Jul 1;146(1):257-70
references.pmid: 301546
references.citation: Proc Natl Acad Sci U S A. 1977 Apr;74(4):1683-7
references.pmid: 266208
references.citation: J Immunol. 1977 Oct;119(4):1248-52
references.pmid: 894033
references.citation: Biochemistry. 1976 Oct 5;15(20):4513-21
references.pmid: 823964
references.citation: Proc Natl Acad Sci U S A. 1976 Sep;73(9):3268-72
references.pmid: 1067618
references.citation: Am J Hematol. 1976;1(4):419-32
references.pmid: 1008055
references.citation: Biochem Biophys Res Commun. 1972 Jul 11;48(1):242-51
references.pmid: 4339463
references.citation: J Exp Med. 1975 Oct 1;142(4):856-63
references.pmid: 1185108
references.citation: J Immunol. 1974 Jul;113(1):348-58
references.pmid: 4134064
references.citation: J Exp Med. 1972 Apr 1;135(4):1003-8
references.pmid: 4111773
references.citation: J Immunol. 1968 Jan;100(1):142-58
references.pmid: 4169693
references.citation: J Exp Med. 1968 Nov 1;128(5):1049-57
references.pmid: 4176223
references.citation: J Immunol. 1976 Mar;116(3):661-8
references.pmid: 176270
references.citation: J Biol Chem. 1973 Dec 10;248(23):8247-53
references.pmid: 4356622
references.citation: J Biol Chem. 1971 Mar 25;246(6):1889-94
references.pmid: 4323238
references.citation: Immunochemistry. 1974 Apr;11(4):203-6
references.pmid: 4212121
references.citation: J Exp Med. 1973 Dec 1;138(6):1305-13
references.pmid: 4202731
references.citation: J Exp Med. 1976 Feb 1;143(2):241-57
references.pmid: 2647
references.citation: Immunochemistry. 1974 Jul;11(7):361-8
references.pmid: 4477550
references.citation: Biochem Soc Trans. 1975;3(1):134-6
references.pmid: 165104
references.citation: Z Immunitatsforsch Exp Klin Immunol. 1976 Apr;151(2):105-16
references.pmid: 134530
references.citation: J Exp Med. 1974 Feb 1;139(2):355-66
references.pmid: 4855753
references.citation: J Immunol. 1973 Oct;111(4):1071-80
references.pmid: 4728677
references.citation: J Immunol. 1973 Jan;110(1):128-38
references.pmid: 4734384
references.citation: J Immunol. 1975 Nov;115(5):1357-61
references.pmid: 809512
references.citation: Annu Rev Biochem. 1975;44:697-724
references.pmid: 1094920
references.citation: Science. 1976 Sep 10;193(4257):1011-3
references.pmid: 948757
references.citation: Proc Natl Acad Sci U S A. 1975 Aug;72(8):3220-4
references.pmid: 1059108
references.citation: J Exp Med. 1975 Oct 1;142(4):974-88
references.pmid: 1185109
references.citation: J Exp Med. 1975 Sep 1;142(3):760-72
references.pmid: 1165475
references.citation: J Biol Chem. 1969 Aug 25;244(16):4406-12
references.pmid: 5806584
references.citation: J Immunol. 1968 Oct;101(4):664-8
references.pmid: 5681648
references.citation: Immunochemistry. 1966 Mar;3(2):111-35
references.pmid: 5960883